Gynamics

Company Overview

Snapshot

Founded in March 2012 by Eyal Bercovich and Isaac Tal, Gynamics operates with 1–10 employees. The company has developed NOLIX, an intra-vaginal medical device, which has successfully completed a proof-of-concept clinical trial and is moving into mass production.

Business overview

Gynamics is a Health Tech & Life Sciences company focused on improving the lives of women suffering from stress urinary incontinence (SUI) and pelvic organ prolapse. The company's core product is NOLIX, an intra-vaginal medical device designed to provide dynamic urethral support using natural abdominal pressure. This air-filled silicone device, resembling a tampon, is intended for over-the-counter purchase and provides up to 12 hours of use. Gynamics operates within the Medical Devices sector, specifically targeting women's health and urology markets globally.

Company Intelligence Q&A

What is Gynamics' primary focus?

Gynamics primarily focuses on developing medical devices to address stress urinary incontinence (SUI) and pelvic organ prolapse in women.

What is NOLIX?

NOLIX is Gynamics' intra-vaginal medical device designed to treat stress urinary incontinence (SUI) by using natural abdominal pressure to create dynamic urethral support. It is an air-filled silicone device intended for over-the-counter purchase and provides up to 12 hours of use.

When was Gynamics founded?

Gynamics was founded in March 2012.

Who are the founders of Gynamics?

Gynamics was founded by Eyal Bercovich and Isaac Tal.

What is the current development stage of the NOLIX device?

The NOLIX device has successfully completed a proof-of-concept clinical trial and is currently moving into mass production.